Denali Therapeutics Inc (DNLI)
24.22
-0.20
(-0.82%)
USD |
NASDAQ |
Nov 21, 16:00
24.95
+0.73
(+3.01%)
After-Hours: 07:22
Denali Therapeutics Shareholders Equity (Quarterly): 1.318B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.318B |
| June 30, 2024 | 1.387B |
| March 31, 2024 | 1.455B |
| December 31, 2023 | 1.031B |
| September 30, 2023 | 1.118B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 966.71M |
| December 31, 2022 | 1.042B |
| September 30, 2022 | 811.30M |
| June 30, 2022 | 884.45M |
| March 31, 2022 | 917.93M |
| December 31, 2021 | 962.29M |
| September 30, 2021 | 1.012B |
| June 30, 2021 | 1.073B |
| March 31, 2021 | 1.105B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.151B |
| September 30, 2020 | 882.55M |
| June 30, 2020 | 502.17M |
| March 31, 2020 | 545.31M |
| December 31, 2019 | 394.89M |
| September 30, 2019 | 438.20M |
| June 30, 2019 | 475.17M |
| March 31, 2019 | 516.65M |
| December 31, 2018 | 546.84M |
| September 30, 2018 | 461.18M |
| June 30, 2018 | 490.27M |
| March 31, 2018 | 539.03M |
| December 31, 2017 | 465.80M |
| September 30, 2017 | 193.14M |
| December 31, 2016 | -94.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
394.89M
Minimum
Dec 2019
1.455B
Maximum
Mar 2024
987.40M
Average
1.022B
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Electromed Inc | 41.49M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.454B |
| Total Liabilities (Quarterly) | 135.52M |